Erasmus School of Health Policy & Management
Visiting fellow | Health Technology Assessment (HTA)
- vangils@eshpm.eur.nl
More information
Work
- Renaud J.S.D. Heine, Ron H.J. Mathijssen, Floor A.J. Verbeek, Chantal Van Gils & Carin A. Uyl-de Groot (2024) - Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands Opent extern - Value in Health, 27 (10), 1367-1372 - doi: 10.1016/j.jval.2024.06.003Opent extern - [link]Opent extern
- D. A. Young-Afat, , C. H. van Gils, H. J.G.D. van den Bongard, H. M. Verkooijen, S. A. Gernaat, M. L. Gregorowitsch, A. M. May, P. H. Peeters, C. C. van der Pol, A. J. Witkamp, R. M. Pijnappel, R. M. Bijlsma, W. Maarse, M. G. Ausems, P. J. van Diest, E. van der Wall, T. van Dalen, I. P. Burgmans, M. A. de Roos, R. C. van Doorn, I. O. Baas, B. van Ooijen & R. Koelemij (2017) - The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results Opent extern - Breast Cancer Research and Treatment, 164 (2), 445-450 - doi: 10.1007/s10549-017-4242-4Opent extern - [link]Opent extern
- L Mohseninejad, Chantal van Gils, Carin Uyl - de Groot, E Buskens & TL (Talitha) Feenstra (2015) - Evaluation of Patient Registries Supporting Reimbursement Decisions: The Case of Oxaliplatin for Treatment of Stage III Colon Cancer Opent extern - Value in Health, 18, 84-90 - doi: 10.1016/j.jval.2014.10.008Opent extern - [link]Opent extern
- Lucas Goossens, Ken Redekop & Chantal van Gils (2015) - Noncollapsibility and Censoring: What's the Bias in Estimating Effects on Survival? Opent extern - Epidemiology, 26 (1), e1-e2 - doi: 10.1097/EDE.0000000000000197Opent extern
- Chantal van Gils, Saskia de Groot, Siok Swan Tan, Ken Redekop, M Koopman, CJ Punt & Carin Uyl - de Groot (2014) - Real-world resource use and costs of adjuvant treatment for stage III colon cancer Opent extern - European Journal of Cancer Care, 24 (3), 321-332 - doi: 10.1111/ecc.12154Opent extern - [link]Opent extern
- Naomi Linden, Chantal van Gils, CP Pescott, J Buter, MR Vergeer & Carin Uyl - de Groot (2014) - Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck Opent extern - European Archives of Oto-Rhino-Laryngology, 272 (8), 2007-2016 - doi: 10.1007/s00405-014-3106-3Opent extern
- Chantal van Gils (2013) - Real-world cost-effectiveness Opent extern - [link]Opent extern
- Naomi Linden, Chantal van Gils, CP Pescott, J Buter & Carin Uyl - de Groot (2013) - Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results Opent extern - European Archives of Oto-Rhino-Laryngology, 271 (6), 1673-1678 - doi: 10.1007/s00405-013-2646-2Opent extern - [link]Opent extern
- Chantal van Gils, Saskia de Groot, Ken Redekop, M Koopman, CJA Punt & Carin Uyl - de Groot (2013) - Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence Opent extern - Pharmacoeconomics (Print), 31 (8), 703-718 - doi: 10.1007/s40273-013-0061-6Opent extern - [link]Opent extern
- Margreet Franken, Chantal van Gils, JG (Jennifer G.) Gaultney, GO Delwel, W Goettsch, PC Huijgens, Adri Steenhoek, CJA Punt, M Koopman, Ken Redekop & Carin Uyl - de Groot (2013) - Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands Opent extern - European Journal of Cancer, 49, 8-16 - doi: 10.1016/j.ejca.2012.06.010Opent extern - [link]Opent extern
- Chantal van Gils, M Koopman, L (Linda) Mol, Ken Redekop, Carin Uyl - de Groot & CJA Punt (2012) - Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in The Netherlands Opent extern - Acta Oncologica, 51, 57-64 - doi: 10.3109/0284186X.2011.633930Opent extern - [link]Opent extern
- Margreet Franken, JG (Jennifer G.) Gaultney, Hedwig Blommestein, Siok Swan Tan, Chantal van Gils, PC Huijgens, Pieter Sonneveld, Ken Redekop & Carin Uyl - de Groot (2012) - Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma Opent extern - [link]Opent extern
- Siok Swan Tan, Chantal van Gils, Margreet Franken, Leona Hakkaart - van Roijen & Carin Uyl - de Groot (2010) - The Unit Costs of Inpatient Hospital Days, Outpatient Visits and Daycare Treatments in the Fields of Oncology and Hematology Opent extern - Value in Health, 13 (6), 712-719 - doi: 10.1111/j.1524-4733.2010.00740.xOpent extern - [link]Opent extern
Master Thesis HEPLOpent extern
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Master Thesis HEOpent extern
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
